arrow
Back
D

David R. Gandara

UC Davis Comprehensive Cancer Center

100H-index
1.1KPaper Count
5.5WCitation Count
Published Papers 133
Publication Date
Prognostic value of patient-reported outcomes for survival in patients with advanced lung cancer receiving immune checkpoint inhibitors
err2025-10-21
err0
errOAAI
errDavid Gandara; Miranda Gogishvili; Ahmet Sezer; Tamta Makharadze; Mahmut Gümüş; Cong Zhu; Eric Yan; Giuseppe Gullo; Petra Rietschel; Ruben G. W. Quek
errShare
errSave
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024
errCancer
IF5.1
err2025-08-26
err0
PREAI
errNarjust Florez MD; Sandip Patel MD; Heather A. Wakelee MD; Julia Rotow MD; Elaine Shum MD; Jacob Sands MD; Ravi Salgia MD, PhD; Fred R. Hirsch MD, PhD; Solange Peters MD, PhD; Joshua Sabari MD; Hatim Husain MD; Lyudmila Bazhenova MD; Erminia Massarelli MD, PhD, MS; Leah M. Backhus MD, MPH; Percy Lee MD; Roy S. Herbst MD, PhD; Christine Bestvina MD; Kristin Higgins MD; Aakash Desai MD, MPH; Martin Dietrich MD, PhD; Hari Balaji Keshava MD, MS; Balazs Halmos MD, MS; David R. Gandara MD; Jonathan Wesley Riess MD, MS; Ana I. Velázquez MD, MSc; Anjali Sibley MD, MPH; Misty Shields MD, PhD; Triparna Sen PhD, MS; Edward S. Kim MD, MBA
errShare
errSave
Brief Report: Safety of Pulse-dose Osimertinib for Treatment of Leptomeningeal Disease or Refractory Brain Metastases in EGFR-mutated Non-small Cell Lung Cancer
err2025-08-06
err0
PREAI
errFangdi Sun; Seema Nagpal; Surbhi Singhal; Joel W. Neal; Heather A. Wakelee; Nathaniel J. Myall; Patrick Bolan; Jonathan W. Riess; David R. Gandara; Millie S. Das
errShare
errSave
Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial
err2025-06-24
err0
errOAAI
errDavid R Spigel; Virginie Westeel; Ian C Anderson; Laurent Greillier; Florian Guisier; Olivier Bylicki; Firas B Badin; Gaelle Rousseau-Bussac; Clotilde Deldycke; Frank Griesinger; Adam Bograd; Wangjian Zhong; Jacques Le Treut; Sylvie Van Hulst; David R Gandara; Martin Reck; Petra Hoffknecht; Matthew A Gubens; John Crowley; Heiko von der Leyen; Gavitt A Woodard; David M Jablons; Johannes R Kratz; Michael J Mann
errShare
errSave
Decoding resistance to immune checkpoint inhibitors in non-small cell lung cancer: a comprehensive analysis of plasma proteomics and therapeutic implications
err2025-05-22
err0
errOAAI
errHarel, Michal; Dahan, Nili; Lahav, Coren; Jacob, Eyal; Elon, Yehonatan; Puzanov, Igor; Kelly, Ronan J.; Shaked, Yuval; Leibowitz, Raya; Carbone, David P.; Gandara, David R.; Dicker, Adam P.
errShare
errSave
Genetic Ancestry and Lung Cancer in Latin American Patients: A Crucial Step for Understanding a Diverse Population
err2025-03-13
err0
PREAI
errJuan Pablo Castañeda-González; Rafael Parra-Medina; Jonathan W. Riess; David R. Gandara; Luis G. Carvajal-Carmona
errShare
errSave
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types
err2025-02-06
err2
errOAAI
errGandara, David R.; Gupta, Shilpa; Klempner, Samuel J.; Andrews, Miles C.; Mahipal, Amit; Subbiah, Vivek; Eskander, Ramez N.; Carbone, David P.; Riess, Jonathan W.; Sammons, Sarah; Snider, Jeremy; Bouzit, Lilia; Cho-Phan, Cheryl; Price, Megan; Li, Gerald; Quintanilha, Julia C. F.; Huang, Richard Sheng Poe; Ross, Jeffrey S.; Fabrizio, David; Oxnard, Geoffrey R.; Graf, Ryon P.
errShare
errSave
S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
err2024-12-01
err0
errOAAI
errTsao, Anne S.; Hsieh, Ming-Hui; Koczywas, Marianna; Tu, Janet; Riess, Jonathan; Tanvetyanon, Tawee; Ma, Barbara T.; Zhao, Ying-Qi; Redman, Mary W.; Edelman, Martin J.; Gandara, David R.; Gray, Jhanelle E.; Kelly, Karen L.
errShare
errSave
Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors
err2024-11-01
err0
PREAI
errReduzzi, Carolina; Nicolo', Eleonora; Singhal, Surbhi; Venetis, Konstantinos; Ortega-Franco, Ana; de Miguel-Perez, Diego; Dipasquale, Angelo; Gouda, Mohamed A.; Saldanha, Erick F.; Kasi, Pashtoon M.; Jantus-Lewintre, Eloisa; Fusco, Nicola; Malapelle, Umberto; Gandara, David R.; Rolfo, Christian; Serrano, Maria Jose; Cristofanilli, Massimo
errShare
errSave
Immune Cell Dynamics in EGFR-Mutated NSCLC Treated With Afatinib and Pembrolizumab: Results From a Phase IB Study
err2024-10-01
err0
errOAAI
errRiess, Jonathan W.; Lara, Matthew S.; de Rodas, Miguel Lopez; Luxardi, Guillaume; Herbert, Samantha; Shimoda, Michiko; Kelly, Karen; Meerlev, Alexander; Moore, Elizabeth; Beckett, Laurel; Monjazeb, Arta; Schalper, Kurt; Maverakis, Emanual; Gandara, David R.
errShare
errSave
Risk model for overall survival (OS) based on composite patient-reported outcomes (PROs) in aNSCLC patients treated with first-line (1L) cemiplimab-based therapy
err2024-09-01
err0
PREAI
errGandara, D. R.; Gogishvili, M.; Sezer, A.; Makharadze, T.; Gumus, M.; Yan, E.; Harnett, J.; Rietschel, P.; Quek, R.
errShare
errSave
Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations
err2024-05-01
err2
errOAAI
errHertz, Daniel L.; Joerger, Markus; Bang, Yung-Jue; Mathijssen, Ron H.; Zhou, Caicun; Zhang, Li; Gandara, David; Stahl, Michael; Monk, Bradley J.; Jaehde, Ulrich; Beumer, Jan H.
errShare
errSave
Plasma proteomics-based models for predicting therapeutic benefit and immunerelated adverse events in non-small cell lung cancer patients treated with immunotherapy
err2024-03-22
err0
PREAI
errHarel, Michal; Christopoulos, Petros; Puzanov, Igor; Bar, Jair; Kamer, Iris; Reinmuth, Niels; Koch, Ina; Moskovitz, Mor; Levy-Barda, Adva; Zer, Alona; Lotem, Michal; Farrugia, David; Katzenelson, Rivka; Price, Gillian; Agbarya, Abed; Cheley, Helen; Hassani, Adam; Abu-Amna, Mahmoud; Geldart, Tom; Chatterjee, Anirban; Polychronis, Andreas; Gottfried, Maya; Lou, Yanyan; Harkovsky, Tatiana; Brewster, Alison; Wolf, Ido; Tepper, Ella; Yellin, Ben; Sela, Itamar; Lahav, Coren; Elon, Yehonatan; Leibowitz, Raya; Dicker, Adam P.; Chae, Young Kwang; Sullivan, Ryan J.; Carbone, David; Gandara, David; Naidoo, Jarushka
errShare
errSave
In Silico dissection of immune infiltrate signatures that are detected by DetermaIO, a predictor of response to immune therapy
err2023-04-04
err0
PREAI
errRing, Brian Z.; Cronister, Catherine T.; Seitz, Robert S.; Ross, Douglas T.; Schweitzer, Brock; Gandara, David R.
errShare
errSave
27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study
err2023-03-01
err4
PREAI
errSaltman, David L.; Varga, Matthew G.; Nielsen, Tyler J.; Croteau, Nicole S.; Lockyer, Heather M.; Jain, Amit L.; Vidal, Gregory A.; Hout, David R.; Schweitzer, Brock L.; Seitz, Robert S.; Ross, Douglas T.; Gandara, David R.
errShare
errSave
Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I
err2023-01-10
err6
PREAI
errUnger, Joseph M.; Qian, Lu; Redman, Mary W.; Tavernier, Susan S.; Minasian, Lori; Sigal, Ellen, V; Papadimitrakopoulou, Vassiliki A.; Leblanc, Michael; Cleeland, Charles S.; Dzingle, Samuel A.; Summers, Thomas J.; Chao, Herta; Madhusudhana, Sheshadri; Villaruz, Liza; Crawford, Jeffrey; Gray, Jhanelle E.; Kelly, Karen L.; Gandara, David R.; Bazhenova, Lyudmila; Herbst, Roy S.; Gettinger, Scott N.; Moinpour, Carol M.
errShare
errSave
Phase 1 Study of Ceritinib Combined With Trametinib in Patients With Advanced ALK- or ROS1-Positive NSCLC
err2022-12-01
err6
errOAAI
errLara, Matthew S.; Gubens, Matthew A.; Bacaltos, Bianca; Daran, Lea; Lim, Steffany L.; Li, Tianhong; Gandara, David R.; Bivona, Trever G.; Riess, Jonathan W.; Blakely, Collin M.
errShare
errSave
A PLASMA PROTEOMIC BASED PREDICTIVE BIOMARKER FOR RESPONSE TO IMMUNOTHERAPY IN NSCLC
err2022-11-07
err0
errOAAI
errHarel, Michal; Lahav, Coren; Wolf, Ido; Tepper, Ella; Gottfried, Maya; Leibowitz, Raya; Abu-Amna, Mahmoud; Agbarya, Abed; Katzenelson, Rivka; Lotem, Michal; Moskovitz, Mor; Zer, Alona; Koch, Ina; Reinmuth, Niels; Dicker, Adam; Gandara, David; Christopoulos, Petros; Carbone, David
errShare
errSave
A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer
err2022-09-07
err11
errOAAI
errWoo, Xing Yi; Srivastava, Anuj; Mack, Philip C.; Graber, Joel H.; Sanderson, Brian J.; Lloyd, Michael W.; Chen, Mandy; Domanskyi, Sergii; Gandour-Edwards, Regina; Tsai, Rebekah A.; Keck, James; Cheng, Mingshan; Bundy, Margaret; Jocoy, Emily L.; Riess, Jonathan W.; Holland, William; Grubb, Stephen C.; Peterson, James G.; Stafford, Grace A.; Paisie, Carolyn; Neuhauser, Steven B.; Karuturi, R. Krishna Murthy; George, Joshy; Simons, Allen K.; Chavaree, Margaret; Tepper, Clifford G.; Goodwin, Neal; Airhart, Susan D.; Lara, Primo N., Jr.; Openshaw, Thomas H.; Liu, Edison T.; Gandara, David R.; Bult, Carol J.
errShare
errSave
Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial
err2022-08-22
err63
errOAAI
errPeters, Solange; Dziadziuszko, Rafal; Morabito, Alessandro; Felip, Enriqueta; Gadgeel, Shirish M.; Cheema, Parneet; Cobo, Manuel; Andric, Zoran; Barrios, Carlos H.; Yamaguchi, Masafumi; Dansin, Eric; Danchaivijitr, Pongwut; Johnson, Melissa; Novello, Silvia; Mathisen, Michael S.; Shagan, Sarah M.; Schleifman, Erica; Wang, Jin; Yan, Mark; Mocci, Simonetta; Voong, David; Fabrizio, David A.; Shames, David S.; Riehl, Todd; Gandara, David R.; Mok, Tony
errShare
errSave